/
NATR
$21.56+$0.54 (+2.57%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$369.6M
18M shares
52-week range
$12.97 – $28.14
57% from low
Sector
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
CS
Borrow rate
0.41%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$4.19
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $364.8M | $362.2M | $385.2M | $444.1M | $421.9M | $445.3M | $454.4M | $480.1M |
| Cost of revenue | $95.7M | $93.9M | $101.3M | $115.5M | $122.2M | $124.2M | $129.7M | $132.4M |
| Gross profit | $269.1M | $268.3M | $283.9M | $328.6M | $299.8M | $321.1M | $324.7M | $347.7M |
| Gross margin | 73.8% | 74.1% | 73.7% | 74.0% | 71.0% | 72.1% | 71.5% | 72.4% |
| R&D | $2.8M | $0 | $0 | $0 | $1.5M | $0 | $1.7M | $0 |
| Operating income | $5.4M | $16.1M | $21.5M | $34.7M | $16.3M | $18.7M | $20.1M | $24.7M |
| EBITDA | $13.5M | $26.3M | $33.7M | $43.2M | $31.1M | $32.1M | $32.8M | $43.8M |
| Net income | −$854.0K | $6.8M | $21.3M | $28.9M | −$390.0K | $15.1M | $7.7M | $19.5M |
| Net margin | -0.2% | 1.9% | 5.5% | 6.5% | -0.1% | 3.4% | 1.7% | 4.1% |
| EPS (diluted) | -0.04 | 0.34 | 1.07 | 1.42 | -0.02 | 0.77 | 0.40 | 1.06 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $508M | $1.21 | $1.20–$1.21 | 1 |
| 2027 | $531M | $1.35 | $1.13–$1.58 | 2 |
| 2028 | $543M | $0.00 | $0.00–$0.00 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$20.22
Price
$21.56
Implied downside
-6%
Peer comparison
Nature's Sunshine Products Inc.
Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products. The following Companies' product lines include: General health: Assorted health products related to blood sugar, bone health, cellular health, etc. Immune: offer products that support and strengthen the human immune system, Cardiovascular: Ingredients to give the cardiovascular system optimum support. Digestive: regulates intestinal and digestive functions, Personal care: personal care products for external use, and Weight management: to simplify the weight management process by providing healthy meal replacements. Business segment: Asia, Europe, North America, Latin America, and Other. The majority of revenue is from Asia.
www.natr.com- Employees
- 806
- IPO / List date
- Aug 7, 1980
- HQ
- LEHI, UT
Held by traders on TradeandTell
No one on the platform currently holds NATR.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 531,924 | $12.8M |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded NATR yet.
